Yes I think they do interim analysis, which would be assessed by the DSMB overseeing the trial to ensure there were no safety concerns. For the company the data is still blinded though so the only comparison they have is overall response rates compared to the phase 2 trial. A previous update said that so far response rates were similar.
Hang in there!!, page-144
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.5¢ |
Change
0.025(5.10%) |
Mkt cap ! $328.0M | |||
| Open | High | Low | Value | Volume |
| 48.5¢ | 52.0¢ | 48.3¢ | $172.5K | 347.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 6682 | 51.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 27796 | 9 |
View Market Depth
| Last trade - 15.08pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
51.0¢ |
Change
0.025 ( 3.34 %) |
||||
| Open | High | Low | Volume | ||
| 48.5¢ | 52.0¢ | 48.5¢ | 82343 | ||
| Last updated 15.25pm 05/06/2024 ? | |||||
| OPT (ASX) Chart |